Preview

Changes in the STR profile of cells in the process of obtaining a stable cell line

https://doi.org/10.17650/1726-9784-2024-23-4-61-67

Abstract

Background. Loss of heterozygosity, loss of the Y chromosome, and other types of genetic alterations are characteristic of tumor cell lines. Standard methods for detecting such changes are effortand time-consuming, and costly. Routine laboratory analysis of the authenticity and absence of intraspecific cell lines contamination using short tandem repeats (STR) profiling also allows for monitoring some genetic changes that cells undergo during the life cycle. The location of some potential STR loci is close to regulatory oncogenic loci, so many researchers note the prognostic and diagnostic utility of using STR profiling at the primary stage of genetic characterization of cell lines.

Aim. Control of cell identity and genetic variability during the establishment of a stable cell line.

Materials and methods. Profiling was carried out for primary cell cultures, for xenografts samples mel Lap nude, mel Kas nude and mel Pet nude, as well as during cell culture at 8th, 10th, 20th passages of the mel Lap, at 10th, 20th passages of the mel Kas and at 5th, 10th, 20th, 49th passages of the mel Pet, as well as after defrosting archived samples.

Results. For the mel Lap culture, by passage 8, a loss of heterozygosity was observed at the SE33 locus, and then the genetic profile remained stable. By passage 10, mel Kas cells lost heterozygosity for two loci SE33 and D6S1043, and in the CSF1PO locus at passage 0, amplification of three alleles was observed – 11, 12, 13. Subsequently, the culture maintained a stable STR profile. By the 5th passage, the mel Pet cell culture lost heterozygosity for almost all the studied loci, but then its STR profile remained unchanged throughout 49 passages and in the xenograft material.

Conclusion. The STR profiling method allows not only to monitor genetic stability in a cell line and the absence of intraspecific contamination during cultivation, but also, being fast and cheap, can be used as an additional primary test for significant genetic changes in cells.

About the Authors

A. A. Malchenkova
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia
Russian Federation

Anastasiia A. Malchenkova

24 Kashirskoe Shosse, Moscow 115522



E. N. Kosobokova
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia
Russian Federation

Ekaterina N. Kosobokova

24 Kashirskoe Shosse, Moscow 115522



References

1. Parson W., Kirchebner R., Mühlmann V. et al. Cancer cell line identification by short tandem repeat profiling: power and limitations. FASEB J 2005;19(3):434–6. DOI: 10.1096/fj.04-3062fje

2. Alves L.N., Wolfgramm E.V., de Castro Neto A.K., Louro I.D. Analysis of microsatellite instability and loss of heterozygosity in ovarian cancer: a study in the population of Espírito Santo, Brazil. Genet Mol Res 2013;12(2):1996–2001. DOI:10.4238/2013.June.14.2

3. Byrom J., Mudaliar V., Redman C.W. et al. Loss of heterozygosity at chromosome 9q22-31 is a frequent and early event in ovarian tumors. Int J Oncol 2004;24(5):1271–7. PMID: 15067351

4. Garcia A., Bussaglia E., Machin P. et al. Loss of heterozygosity on chromosome 17q in epithelial ovarian tumors: association with carcinomas with serous differentiation. Int J Gynecol Pathol 2000;19(2):152–7. DOI: 10.1097/00004347-200004000-00009

5. Huang X., Weimer J., von Wurmb-Schwark N. et al. Alteration of STR profiles in ovarian carcinoma cells during primary culture. Arch Gynecol Obstet 2016;294(2):369–76. DOI: 10.1007/s00404-016-4018-9

6. Risinskaya N.V, Kozhevnikova Y.A., Kovaleva V.A. et al. Loss of heterozygosity in the short tandem repeat (STR) profile of tumor DNA of de novo diagnosed ALL patients as a pattern of abnormal karyotype. Kletochnaya terapiya i transplantologiya = CTT Journal 2020;9(3):22–3. (In Russ.).

7. Nikulina E.E., Firsova M.V., Risinskaya N.V. et al. Evaluation of heterozygosity loss in STR-loci of tumor DNA in multiple myeloma patients with plasmacytoma based on the molecular analysis of complex archival tumor samples. Klinicheskaya onkogematologiya = Clinical Oncohematology 2022;15(2): 156–66. (In Russ.). DOI: 10.21320/2500-2139-2022-15-2-156-166

8. Kosobokova E.N., Kalinina N.A., Konoplina K.M. et al. Human metastatic melanoma cell lines panel for in vitro and in vivo investigations. Mol Pathol 2024;5(1):11–27. DOI:10.3390/jmp5010002

9. ANSI/ATCC ASN-0002-2022: Authentication of Human Cell Lines: Standardization of Short Tandem Repeat (STR) Profiling. URL: https://webstore.ansi.org/standards/atcc/ansiatccasn00022022.

10. Kosobokova E.N., Malchenkova A.A., Kalinina N.A., Kosorukov V.S. Using short tandem repeat profiling to validate cell lines in biobanks. Kardiovaskulyarnaya terapiya i profilaktika = Cardiovascular Therapy and Prevention. 2022;21(11):3386. (In Russ.). DOI: 10.15829/1728-8800-2022-3386

11. Tanabe H., Takada Y., Minegishi D. et al. Cell line individualization by STR multiplex system in the cell bank found cross-contamination between ECV304 and EJ-1/T24. Tissue Cult Res Commun 1999;18:329–38. DOI: 10.11418/jtca1981.18.4_329


Review

For citations:


Malchenkova A.A., Kosobokova E.N. Changes in the STR profile of cells in the process of obtaining a stable cell line. Russian Journal of Biotherapy. 2024;23(4):61-67. (In Russ.) https://doi.org/10.17650/1726-9784-2024-23-4-61-67

Views: 1157


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1726-9784 (Print)
ISSN 1726-9792 (Online)